BeStock  
Stocks › CLDX

Celldex Therapeutics CLDX

US equityMarket cap rank #2602Biotechnology
$32.59 +$0.94 (+2.97%)
Market closed · Oct 6, 4:20 am ET · Last extended-hours $32.59 0.00%
Open$31.83
Prev close$31.65
Day range$31.50 – $32.88
Volume1.26M
Market cap$2.56B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.5x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average -12.9x

Morningstar fair value estimate

Fair value$31.49
Price vs. fair value+3.5%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -7.49 -7.63 -12.88 92% (pricier than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$31.49
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on CLDX.

Leave a comment

Scroll to Top